BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17078854)

  • 1. Vascularity in thyroid neoplasms: a methodological investigation with a view to diagnostics.
    Larsen KK; Andersen NF; Melsen F; Sørensen FB
    APMIS; 2006 Nov; 114(11):749-56. PubMed ID: 17078854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density.
    Hansen S; Grabau DA; Rose C; Bak M; Sørensen FB
    Lab Invest; 1998 Dec; 78(12):1563-73. PubMed ID: 9881956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerized nuclear morphometry and quantitation of angiogenesis in thyroid neoplasms.
    Kavantzas N; Tseleni-Balafouta S; Davaris P
    J Exp Clin Cancer Res; 2002 Jun; 21(2):247-54. PubMed ID: 12148586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid tumours: comparison of different methods of assessing vascularity.
    Wong NA; Willott J; Kendall MJ; Sheffield EA
    J Clin Pathol; 1999 Aug; 52(8):593-7. PubMed ID: 10645229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular density has prognostic value in Merkel cell carcinoma.
    Ng L; Beer TW; Murray K
    Am J Dermatopathol; 2008 Oct; 30(5):442-5. PubMed ID: 18806485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer.
    Suhonen KA; Anttila MA; Sillanpää SM; Hämäläinen KM; Saarikoski SV; Juhola M; Kosma VM
    Eur J Cancer; 2007 May; 43(8):1300-7. PubMed ID: 17448653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma.
    Wang SL; Li SH; Chen WT; Chai CY
    APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
    Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
    Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemangiosarcoma of the thyroid gland. Histological diagnosis problems.
    Hălălău F; Laky D
    Morphol Embryol (Bucur); 1983; 29(3):195-6. PubMed ID: 6199664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
    Shi L; Chen XM; Wang L; Zhang L; Chen Z
    Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of MMP-9 and CD34 in papillary thyroid carcinomas].
    Zhang HB; Wei QY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):427-8. PubMed ID: 14653139
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
    Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
    Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors.
    Takahashi Y; Akishima-Fukasawa Y; Kobayashi N; Sano T; Kosuge T; Nimura Y; Kanai Y; Hiraoka N
    Clin Cancer Res; 2007 Jan; 13(1):187-96. PubMed ID: 17200354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
    Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
    Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
    Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
    Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
    El Demellawy D; Nasr AL; Babay S; Alowami S
    Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis.
    Ohno F; Nakanishi H; Abe A; Seki Y; Kinoshita A; Hasegawa Y; Tatematsu M; Kurita K
    J Oral Pathol Med; 2007 May; 36(5):281-9. PubMed ID: 17448138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
    Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
    Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.